glp 1 agonist retatrutide Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide 10mg Triple Agonist |
Description
The approval marks the first new biologic treatment option for HS in almost a decade, according to Novartis announcement

This is particularly true for people with hemophilic arthropathy (joint damage), which can make movement and exercise more difficult

Going slower beats fighting through

To put that in context, it exceeded what Semaglutide and Tirzepatide produced in their own trials, and the mechanism responsible was almost entirely reduced food intake driven by lower appetite

Increased heart rate may occur, even when at rest

There have been a couple of incidents of diarrhea or constipation, but severe events are uncommon